DDC Medical, a division of DNA Diagnostics Center, offers human cell line identification and mycoplasma detection services. Studies have found an alarming percentage of human cell lines purchased from commercial repositories can be contaminated or misidentified. In addition, genetic instability of some cell lines can result in changes at the DNA level that can compromise research results. Articles published on these topics indicate as much as 20 to 33 percent of all cell lines are misidentified or contaminated, but there is a simple and affordable solution.
Peer review journals throughout the research community recommends cell line Identification and mycoplasma detection as part of the publication process. Grant providers are also aware of the issue and requiring cell line identification and mycoplasma detection ensures a sound investment.
Who might be interested in this test?
• Academic researchers and teaching labs
• Pharma labs and researchers
• Biotech labs and researchers
• Government labs and researchers
• Other private and non-profit cancer and cell-based research institutions
When should cell line identification be completed?
• When a new line is first established or purchased
• As a control measure at the start of a new study and concluding a study
• At least once every 6 months in active culture
• Before freezing down for storage
• When an unexpected result occurs